Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-871-2 | CAS number: 6613-31-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 8-(butan-2-yl)-5,6,7,8-tetrahydroquinoline
- EC Number:
- 938-871-2
- Cas Number:
- 6613-31-6
- Molecular formula:
- C13H19N
- IUPAC Name:
- 8-(butan-2-yl)-5,6,7,8-tetrahydroquinoline
Constituent 1
Results and discussion
Any other information on results incl. tables
The test item GR-50-0572 was assessed for its potential to induce gene mutations in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration and the controls were tested in triplicate. The test item was tested at the following concentrations: Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 Mg/plate Experiment II without S9 mix Salmonella typhimurium: 0.3; 1; 3; 10; 33; 100; 333; and 1000 Mg/plate Escherichia coli: 1; 3; 10; 33; 100; 333; 1000; and 2500 Mg/plate Experiment II with S9 mix: 1; 3; 10; 33; 100; 333; 1000; and 2500 Mg/plate Reduced background growth was observed at the following concentrations (Mg/plate): Strain Experiment I Experiment II without S9 mix with S9 mix without S9 mix with S9 mix TA 1535 100 - 5000 333 - 5000 33 - 1000 333 - 2500 TA 1537 100 - 5000 333 - 5000 33 - 1000 100 - 2500 TA 98 100 - 5000 333 - 5000 33 - 1000 333 - 2500 TA 100 100 - 5000 333 - 5000 33 - 1000 100 - 2500 WP2 uvrA 333 - 5000 1000 - 5000 100 - 2500 333 - 2500 Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in the test groups at the following concentrations (Mg/plate): Strain Experiment I Experiment II without S9 mix with S9 mix without S9 mix with S9 mix TA 1535 333 - 5000 333 - 5000 333, 1000 333 - 2500 TA 1537 333 - 5000 1000 - 5000 333, 1000 333 - 2500 TA 98 333 - 5000 1000 - 5000 333, 1000 333 - 2500 TA 100 333 - 5000 1000 - 5000 333, 1000 333 - 2500 WP2 uvrA 1000 - 5000 1000 - 5000 1000, 2500 333 - 2500 No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with GR-50-0572 at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies. In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In conclusion, it can be stated that during the described mutagenicity test and under the
experimental conditions reported, the test item did not induce gene mutations by base pair
changes or frameshifts in the genome of the strains used.
Therefore, GR-50-0572 is considered to be non-mutagenic in this Salmonella typhimurium
and Escherichia coli reverse mutation assay. - Executive summary:
This study was performed to investigate the potential of GR-50-0572 to induce gene mutations in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations: Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 Mg/plate Experiment II without S9 mix Salmonella typhimurium: 0.3; 1; 3; 10; 33; 100; 333; and 1000 Mg/plate Escherichia coli: 1; 3; 10; 33; 100; 333; 1000; and 2500 Mg/plate Experiment II with S9 mix: 1; 3; 10; 33; 100; 333; 1000; and 2500 Mg/plate The plates incubated with the test item showed reduced background growth with and without metabolic activation in both independent experiments. Distinct toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in the test groups with and without metabolic activation in both independent experiments. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with GR-50-0572 at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.